FDA Delays Approval of Actemra
The FDA has delayed approval for Actemra pending submission of extra product manufacturing and product label information by the drug manufacturer, Roche Holding AG. This comes a week after requiring ordering label changes for Rituxan, which is manufactured by Genentech and... Read more








